Biomedical engineering principles of modern cochlear implants and recent surgical innovations

Anatomical Record

Volumn 295, Issue 11, 2012, Pages 1957-1966

  Eshraghi, Adrien A ^a   Gupta, Chhavi ^a   Ozdamar, Ozcan ^b   Balkany, Thomas J ^a   Truy, Eric ^c   Nazarian, Ronen ^a  

^a UNIVERSITY OF MIAMI EAR INSTITUTE   (United States)

^b University of Miami College of Engineering   (United States)

^c ECOLE NORMALE SUPÉRIEURE   (France)

Author keywords

Biomedical engineering; Cochlear implant; Cochlear implant trauma; Hearing preservation; Temporalis pocket

Indexed keywords

AGENTS ACTING ON THE AUDITORY AND VESTIBULAR SYSTEMS; AM 111; DEXAMETHASONE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; AUDIOMETRY; AUDITORY STIMULATION; BINAURAL HEARING; BIOMECHANICS; BIOMEDICAL ENGINEERING; CELL LOSS; CLINICAL TRIAL (TOPIC); COCHLEA PROSTHESIS; DRUG DELIVERY SYSTEM; DRUG EFFICACY; EAR PROTECTION; EAR SURGERY; ELECTRIC CURRENT; ELECTROSTIMULATION; GENETIC SUSCEPTIBILITY; HEARING IMPAIRMENT; HUMAN; IMPLANTATION; INFORMATION PROCESSING; MENIERE DISEASE; NONHUMAN; PERCEPTION DEAFNESS; PRIORITY JOURNAL; RADIOFREQUENCY; SIGNAL PROCESSOR; TISSUE INJURY; TREATMENT OUTCOME;

ANIMALS; BIOMEDICAL ENGINEERING; COCHLEAR IMPLANTATION; HEARING LOSS; HUMANS;

EID: 84867897330     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.22584     Document Type: Article

References (55)

1. Balkany TJ, Eshraghi AA, Jiao H, Polak M, Mou C, Dietrich DW, Van De Water TR. 2005. Mild hypothermia protects auditory function during cochlear implant surgery. Laryngoscope 115: 1543-1547.
2. Balkany TJ, Whitley M, Shapira Y, Angeli SI, Brown K, Eter E, Van De Water T, Telischi FF, Eshraghi AA, Treaba C. 2009. The temporalis pocket technique for cochlear implantation: an anatomic and clinical study. Otol Neurotol 30: 903-907.
3. Baskent D, Shannon RV. 2003. Speech recognition under conditions of frequency-place compression and expansion. JASA 113: 2064-2076.
4. Bilecen D, Seifritz E, Radü EW, Schmid N, Wetzel S, Probst R, Scheffler K. 2000. Cortical reorganization after acute unilateral hearing loss traced by fMRI. Neurology 54: 765-767.
5. Blamey PJ, Parisi E, Clark GM. 1995. Pitch matching of electric and acoustic stimuli. Ann Otol Rhinol Laryngol 104: 220-222.
6. Blamey PJ, Dooley GJ, Parisi ES, Clark GM. 1996. Pitch comparisons of acoustically and electrically evoked auditory sensations. Hear Res 99: 139-150.
7. Buss E, Pillsbury HC, Buchman CA, Pillsbury CH, Clark MS, Haynes DS, Labadie RF, Amberg S, Roland PS, Kruger P, Novak MA, Wirth JA, Black JM, Peters R, Lake J, Wackym PA, Firszt JB, Wilson BS, Lawson DT, Schatzer R, D'Haese PS, Barco AL. 2008. Multicenter U.S. bilateral MED-EL cochlear implantation study: speech perception over the first year of use. Ear Hear 29: 20-32.
8. Carroll J, Tiaden S, Zeng FG. 2011. Fundamental frequency is critical to speech perception in noiser in combined acoustic and electric hearing. J Acoust Soc Am 130: 2054-2062.
9. Clark GM. 2006. The multiple-channel cochlear implant: the interface between sound and the central nervous system for hearing, speech, and language in deaf people-a personal perspective. Philos Trans R Soc Lond B Biol Sci 361: 791-810.
10. Cohen-Kerem R, Kisilevsky V, Einarson TR, Kozer E, Koren G. 2004. Intratympanic gentamicin for Menière's disease: a meta-analysis. Laryngoscope 114: 2085-2091.
11. Cokely JA, Hall JW, III. 1991. Frequency resolution for diotic and dichotic listening conditions compared using the band limiting measure and a modified band limiting measure. J Acoust Soc Am 89: 1331-1339.
12. Djalilian HR, King T, Faust RA, Smith S, Levine SC. 2001. Securing cochlear implants to the skull: two alternate methods. Ear Nose Throat J 80: 171-173.
13. Eshraghi AA. 2006. Prevention of cochlear implant electrode damage. Curr Opin Otolaryngol Head Neck Surg 14: 323-328.
14. Eshraghi AA, Gupta C, Van De Water RT, Bohorquez EJ, Garnham C, Bas E, Talamo MV. 2012. Molecular Mechanisms Involved in Cochlear Implantation Trauma and the Protection of Hearing and Auditory Sensory Cells by Inhibition of c-Jun-N-Terminal Kinase Signaling. The Laryngoscope: In publication.
15. Eshraghi AA, Adil E, He J, Graves R, Balkany TJ, Van De Water TR. 2007a. Local dexamethasone therapy conserves hearing in an animal model of electrode insertion trauma-induced hearing loss. Otol Neurotol 28: 842-849.
16. Eshraghi AA, Dinh CT, Bohorquez J, Angeli S, Abi-Hachem R, Van De Water TR. 2011. Local drug delivery to conserve hearing: mechanisms of action of eluted dexamethasone within the cochlea. Cochlear Implants Internat 12 ( Suppl 1): S51-S53.
17. Eshraghi AA, He J, Mou CH, Polak M, Zine A, Bonny C, Balkany TJ, Van De Water TR. 2006. D-JNKI-1 treatment prevents the progression of hearing loss in a model of cochlear implantation trauma. Otol Neurotol 27: 504-511.
18. Eshraghi AA, Polak M, He J, Telischi FF, Balkany TJ, Van De Water TR. 2005. Pattern of hearing loss in a rat model of cochlear implantation trauma. Otol Neurotol 26: 442-447.
19. Eshraghi AA, Wang J, Adil E, He J, Zine A, Bublik M, Bonny C, Puel JL, Balkany TJ, Van De Water TR. 2007b. Blocking c-Jun-N-terminal kinase signaling can prevent hearing loss induced by both electrode insertion trauma and neomycin ototoxicity. Hear Res 226: 168-177.
20. Eshraghi AA, Yang NW, Balkany TJ. 2003. Comparative study of cochlear damage with three perimodiolar electrode designs. Laryngoscope 113: 415-419.
21. Fitzgerald, MB, Sagi E, Jackson M, Shapiro WH, Roland JT, Jr., Waltzman SB, Svirsky MA. 2008. Reimplantation of hybrid cochlear implant users with a full-length electrode after loss of residual hearing. Otol Neurotol 29: 168-173.
22. Forge A, Li L. 2000. Apoptotic death of hair cells in mammalian vestibular sensory epithelia. Hear Res 139: 97-115.
23. Fu QJ, Shannon RV, Wang X. 1998. Effects of noise and spectral resolution on vowel and consonant recognition: acoustic and electrichearing. J Acoust Soc Am 104: 3586-3596.
24. Gantz BJ, Dunn CC, Walker EA, Kenworthy M, Van Voorst T, Tomblin B, Turner C. 2010. Bilateral cochlear implants in infants: a new approach-Nucleus Hybrid S12 project. Otol Neurotol l31: 1300-1309.
25. Gooler DM, Xu J, Feng AS. 1996. Binaural inhibition is important in shaping the free-field frequency selectivity of single neurons in the inferior colliculus. J Neurophysiol 76: 2580-2594.
26. Gouveris H, Selivanova O, Mann W. 2005. Intratympanic dexamethasone with hyaluronic acid in the treatment of idiopathic sudden sensorineural hearing loss after failure of intravenous steroid and vasoactive therapy. Eur Arch Otorhinolaryngol 262: 131-134.
27. Gstoettner W, Helbig S, Settevendemie C, Baumann U, Wagenblast J, Arnoldner C. 2009. A new electrode for residual hearing preservation in cochlear implantation: first clinical results. Acta Otolaryngol 129: 372-379.
28. James DP, Eastwood H, Richardson RT, O'Leary SJ. 2008. Effects of round window dexamethasone on residual hearing in a Guinea pig model of cochlear implantation. Audiol Neurootol 3: 86-96.
29. Lan N, Nie KB, Gao SK, Zeng FG. 2004. A novel speech-processing strategy incorporating tonal information for cochlear implants. IEEE Trans Biomed Eng 51: 752-760.
30. Lawson DT, Wilson BS, Zerbi M, van den Honert C, Finley CC, Farmer JC, Jr., McElveen JT, Jr., Roush PA. 1998. Bilateral cochlear implants controlled by a single speech processor. Am J Otol 19: 758-761.
31. Litovsky RY, Parkinson A, Arcaroli J, Peters R, Lake J, Johnstone P, Yu G. 2004. Bilateral cochlear implants in adults and children. Arch Otolaryngol Head Neck Surg 130: 648-655.
32. Loizou PC, Dorman M, Tu Z. 1999. On the number of channels needed to understand speech. J Acoustic Soc Am 106( 4 Part 1): 2097-2103.
33. McCullough JA, Abbas PJ. 1992. Effects of interaural speech-recognition differences on binaural advantage for speech in noise. J Am Acad Audiol 3: 255-261.
34. Müller J, Schön F, Helms J. 2002. Speech understanding in quiet and noise in bilateral users of the MED-EL COMBI 40/40+ cochlear implant system. Ear Hear 23: 198-206.
35. Neuman AC, Haravon A, Sislian N, Waltzman SB. 2007. Sound-direction identification with bilateral cochlear implants. Ear Hear 28: 73-82.
36. Paulson DP, Abuzeid W, Jiang H, Oe T, O'Malley BW, Li D. 2008. A novel controlled local drug delivery system for inner ear disease. Laryngoscope 118: 706-711.
37. Plontke SK, Biegner T, Kammerer B, Delabar U, Salt AN. 2008. Dexamethasone concentration gradients along scala tympani after application to the round window membrane. Otol Neurotol 29: 401-406.
38. Plontke SK, Löwenheim H, Mertens J, Engel C, Meisner C, Weidner A, Zimmermann R, Preyer S, Koitschev A, Zenner HP. 2009. Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy. Laryngoscope 119: 359-369.
39. Rauch SD. 2004. Intratympanic steroids for sensorineural hearing loss. Otolaryngol Clin North Am 37: 1061-1074.
40. Roland JT. 2000. Complications of cochlear implant surgery. In: Waltzman SB, Cohen NL, editors. Cochlear implants. Teningen, Germany: Thieme. p 171Y5.
41. Salt AN, Plontke SK. 2009. Principles of local drug delivery to the inner ear. Audiol Neurootol 4: 350-360.
42. Schoen F, Mueller J, Helms J, Nopp P. 2005. Sound localization and sensitivity to interaural cues in bilateral users of the Med-El Combi 40/40+cochlear implant system. Otol Neurotol 26: 429-437.
43. Shannon RV. 1983. Multichannel electrical stimulation of the auditory nerve in man. I. Basic psychophysics. Hear Res 11: 157-189.
44. Suckfuell M, Canis M, Strieth S, Scherer H, Haisch A. 2007. Intratympanic treatment of acute acoustic trauma with a cell-permeable JNK ligand: a prospective randomized phase I/II study. Acta Otolaryngol 127: 938-942.
45. Tajudeen BA, Waltzman SB, Jethanamest D, Svirsky MA. 2010. Speech perception in congenitally deaf children receiving cochlear implants in the first year of life. Otol Neurotol 31: 1254-1260.
46. Truy E, Ionescu E, Ceruse P, Gallego S. 2002. The binaural digisonic cochlear implant: surgical technique. Otol Neurotol 23: 704-709.
47. van Deun L, van Wieringen A, Scherf F, Deggouj N, Desloovere C, Offeciers FE, Van de Heyning PH, Dhooge IJ, Wouters J. 2010. Earlier intervention leads to better sound localization in children with bilateral cochlear implants. Audiol Neurootol 15: 7-17.
48. van Hoesel RJ, Clark GM. 1997. Psychophysical studies with two binaural cochlear implant subjects. J Acoustic Soc Am 102: 495-507.
49. Vivero RJ, Joseph DE; Angeli S, He J, Chen S, Eshraghi AA, Balkany TJ, Van De Water TR. 2008. Dexamethasone base conserves hearing from electrode trauma-induced hearing loss. Laryngoscope 111: 2028-2035.
50. von Ilberg C, Kiefer J, Tillein J, Pfennigdorff T, Hartmann R, Stürzebecher E, Klinke R. 1999. Electric-acoustic stimulation of the auditory system. ORL 61: 334-340.
51. Wang X, Dellamary L, Fernandez R, Harrop A, Keithley EM, Harris JP, Ye Q, Lichter J, LeBel C, Piu F. 2009. Dose dependent sustained release of dexamethasone in inner ear cochlear fluids using a novel local delivery approach. Audiol Neurootol 14: 393-401.
52. Wilson BS, Dorman MF. 2008. Cochlear implants: a remarkable past and a brilliant future. Hear Res 242: 3-21.
53. Wilson BS, Finley CC, Lawson DT, Wolford RD, Eddington DK, Rabinowitz WM. 1991. Better speech recognition with cochlear implants. Nature 352: 236-238.
54. Woodson EA, Reiss LA, Turner CW, Gfeller K, Gantz BJ. 2010. The Hybrid cochlear implant: a review. Adv Otorhinolaryngol 67: 125-134.
55. Zeng FG, Rebscher S, Harrison W, Sun X, Feng H. 2008. Cochlear implants: system design, integration, and evaluation. IEEE Rev Biomed Eng 1: 115-141.